← Browse by Condition
Medical Condition
peripheral primitive neuroectodermal tumor
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT06441331 Phase 1
Recruiting
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Enrollment
20 pts
Location
United States, Spain
Sponsor
ITM Solucin GmbH
NCT06068075
Recruiting
Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD
Enrollment
340 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute